Literature DB >> 26992699

Species differences in the effects of the κ-opioid receptor antagonist zyklophin.

Sunil Sirohi1, Jane V Aldrich2, Brendan M Walker3.   

Abstract

We have shown that dysregulation of the dynorphin/kappa-opioid receptor (DYN/KOR) system contributes to escalated alcohol self-administration in alcohol dependence and that KOR antagonists with extended durations of action selectively reduce escalated alcohol consumption in alcohol-dependent animals. As KOR antagonism has gained widespread attention as a potential therapeutic target to treat alcoholism and multiple neuropsychiatric disorders, we tested the effect of zyklophin (a short-acting KOR antagonist) on escalated alcohol self-administration in rats made alcohol-dependent using intermittent alcohol vapor exposure. Following dependence induction, zyklophin was infused centrally prior to alcohol self-administration sessions and locomotor activity tests during acute withdrawal. Zyklophin did not impact alcohol self-administration or locomotor activity in either exposure condition. To investigate the neurobiological basis of this atypical effect for a KOR antagonist, we utilized a κ-, μ-, and δ-opioid receptor agonist-stimulated GTPyS coupling assay to examine the opioid receptor specificity of zyklophin in the rat brain and mouse brain. In rats, zyklophin did not affect U50488-, DAMGO-, or DADLE-stimulated GTPyS coupling, whereas the prototypical KOR antagonist nor-binaltorphimine (norBNI) attenuated U50488-induced stimulation in the rat brain tissue at concentrations that did not impact μ- and δ-receptor function. To reconcile the discrepancy between the present rat data and published mouse data, comparable GTPyS assays were conducted using mouse brain tissue; zyklophin effects were consistent with KOR antagonism in mice. Moreover, at higher concentrations, zyklophin exhibited agonist properties in rat and mouse brains. These results identify species differences in zyklophin efficacy that, given the rising interest in the development of short-duration KOR antagonists, should provide valuable information for therapeutic development efforts.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol dependence and withdrawal; Alcohol self-administration; GTPyS coupling; Kappa-opioid receptor; Zyklophin

Mesh:

Substances:

Year:  2016        PMID: 26992699      PMCID: PMC4879959          DOI: 10.1016/j.alcohol.2015.11.012

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  48 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Impaired control and undergraduate problem drinking.

Authors:  Robert F Leeman; Miriam Fenton; Joseph R Volpicelli
Journal:  Alcohol Alcohol       Date:  2006-12-02       Impact factor: 2.826

Review 3.  Drug efficacy at G protein-coupled receptors.

Authors:  Terry Kenakin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

4.  Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients.

Authors:  J M Hiller; Y Itzhak; E J Simon
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

5.  Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice.

Authors:  K M Dimattio; T V Yakovleva; J V Aldrich; A Cowan; L Y Liu-Chen
Journal:  Neurosci Lett       Date:  2014-02-03       Impact factor: 3.046

Review 6.  Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.

Authors:  Brendan M Walker; Glenn R Valdez; Jay P McLaughlin; Georgy Bakalkin
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

Review 7.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Authors:  Marcella Martignoni; Geny M M Groothuis; Ruben de Kanter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

8.  Biased agonism.

Authors:  Terry Kenakin
Journal:  F1000 Biol Rep       Date:  2009-11-26

Review 9.  Long-acting injectable naltrexone for the treatment of alcohol dependence.

Authors:  Paolo Mannelli; Kathleen Peindl; Prakash S Masand; Ashwin A Patkar
Journal:  Expert Rev Neurother       Date:  2007-10       Impact factor: 4.618

10.  Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure.

Authors:  Laura E O'Dell; Amanda J Roberts; Ron T Smith; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2004-11       Impact factor: 3.455

View more
  2 in total

1.  Enhancement of a Heroin Vaccine through Hapten Deuteration.

Authors:  Tyson F Belz; Paul T Bremer; Bin Zhou; Beverly Ellis; Lisa M Eubanks; Kim D Janda
Journal:  J Am Chem Soc       Date:  2020-07-27       Impact factor: 15.419

Review 2.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.